Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,099
Closed -$211K 2260
2026
Q1
$211K Buy
+11,099
New +$214K ﹤0.01% 1251
2025
Q1
Sell
-32,640
Closed -$387K 2233
2024
Q4
$387K Sell
32,640
-64,396
-66% -$1.01M 0.01% 980
2024
Q3
$1.74M Buy
+97,036
New +$1.77M 0.03% 520
2024
Q1
Sell
-20,704
Closed -$540K 2334
2023
Q4
$540K Sell
20,704
-22,442
-52% -$512K 0.01% 925
2023
Q3
$995K Buy
+43,146
New +$1.08M 0.02% 648
2022
Q2
Sell
-20,574
Closed -$619K 2038
2022
Q1
$619K Buy
20,574
+13,360
+185% +$417K 0.01% 884
2021
Q4
$207K Sell
7,214
-8,537
-54% -$278K ﹤0.01% 995
2021
Q3
$632K Buy
+15,751
New +$704K 0.04% 539
2021
Q2
Sell
-6,312
Closed -$238K 1658
2021
Q1
$238K Buy
+6,312
New +$269K 0.01% 901

Other funds holding XP

Centiva Capital's XP Position: Q2 2026 in Review

Centiva Capital sold out of XP (XP) in Q2 2026, closing a stake of 11,099 shares — an estimated $211K sold.

Centiva Capital first reported a position in XP in Q1 2021 and held it in 9 quarters. The position peaked at $1.74M in Q3 2024. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Centiva Capital reported no remaining XP position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 11,099 XP shares in Q2 2026, an estimated $211K.
  • Centiva Capital first reported a position in XP in Q1 2021 and held it in 9 quarters.
  • Centiva Capital's XP position peaked at $1.74M in Q3 2024.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.